Mixlab Acquires NexGen Animal Health to Expand into Large-Animal Compounding
May 22, 2024
Mixlab has acquired NexGen Animal Health, a Weatherford, Texas-based veterinary compounding specialist, to expand its sterile and non-sterile formulation capabilities into equine, exotic, wildlife and zoo markets. The acquisition — completed with continued financial backing from Vanterra Ventures and other investors — adds a fourth pharmacy location in Texas and enables Mixlab to leverage its proprietary eMix platform to increase production efficiency and broaden its large-animal offering.
- Buyers
- Mixlab
- Targets
- NexGen Animal Health
- Industry
- Veterinary
- Location
- Texas, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Zoetis to Acquire Neogen’s Animal Genomics Business for $160 Million
March 3, 2026
Healthcare Services
Zoetis announced it has entered into a definitive agreement to acquire Neogen Corporation’s animal genomics business for $160 million, subject to customary closing adjustments. The deal is intended to strengthen Zoetis’ leadership in Precision Animal Health by integrating Neogen’s genomic technologies and data solutions to expand predictive insights and individualized care.
-
Colossal Biosciences Acquires Viagen Pets and Equine
November 7, 2025
Biotechnology
Colossal Biosciences has acquired Viagen Pets and Equine, a Texas-based leader in animal cloning, cryopreservation, and genetic preservation, which will operate as a wholly owned subsidiary under its existing leadership. The deal expands Colossal’s de‑extinction and species preservation platform, bringing Viagen’s cloning expertise, biobanking capabilities and a ~25‑person team into Colossal’s conservation pipeline.
-
Zoetis Completes Acquisition of Jurox
September 30, 2022
Pharmaceuticals
Zoetis Inc. has completed its acquisition of Jurox, a privately held Australian animal health company that develops, manufactures and markets veterinary medicines, including the anaesthetic Alfaxan. The deal expands Zoetis' veterinary product portfolio and manufacturing capabilities in Australia and supports greater global distribution of Jurox products.
-
Dechra Pharmaceuticals Acquires Med-Pharmex from DW Healthcare Partners
August 30, 2022
Veterinary
Dechra Pharmaceuticals PLC has completed the acquisition of Med-Pharmex Holdings, Inc. from DW Healthcare Partners. The deal brings a US-based, fully integrated veterinary pharmaceutical manufacturer (Med-Pharmex) into Dechra's global animal-health platform to strengthen its manufacturing capabilities and North American footprint.
-
LGM Pharma Acquires Nexgen Pharma's Drug Product CDMO Business
July 23, 2020
Pharmaceuticals
LGM Pharma has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma, expanding LGM's CDMO capabilities and U.S.-based manufacturing footprint. Financial support for the transaction was provided by private equity firm New Harbor Capital; Nexgen Pharma sold its pharmaceutical CDMO unit to allow the company to focus on other healthcare segments.
-
Zoetis Acquires Phoenix Central Laboratory (Phoenix Lab)
October 31, 2019
Veterinary
Zoetis has completed the acquisition of Phoenix Central Laboratory for Veterinarians, Inc. (Phoenix Lab), a Mukilteo, Washington-based veterinary reference laboratory. The purchase expands Zoetis's diagnostics capabilities by adding reference laboratory services to its existing point-of-care diagnostic portfolio; financial terms were not disclosed.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.